$CHE
CHEMED CORP

2024 Q1 Form 10-Q Financial Statement

#000156276224000106 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1
Revenue $589.2M
YoY Change 5.19%
Cost Of Revenue $385.1M
YoY Change 3.89%
Gross Profit $204.1M
YoY Change 7.73%
Gross Profit Margin 34.64%
Selling, General & Admin $115.9M
YoY Change 15.76%
% of Gross Profit 56.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.81M
YoY Change 6.82%
% of Gross Profit 7.74%
Operating Expenses $115.9M
YoY Change 15.76%
Operating Profit $72.33M
YoY Change -0.67%
Interest Expense $425.0K
YoY Change -72.6%
% of Operating Profit 0.59%
Other Income/Expense, Net $12.58M
YoY Change -12310.68%
Pretax Income $84.49M
YoY Change 18.72%
Income Tax $19.47M
% Of Pretax Income 23.04%
Net Earnings $65.02M
YoY Change 20.13%
Net Earnings / Revenue 11.03%
Basic Earnings Per Share $4.30
Diluted Earnings Per Share $4.24
COMMON SHARES
Basic Shares Outstanding 15.12M
Diluted Shares Outstanding 15.34M

Balance Sheet

Concept 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $313.4M
YoY Change 439.76%
Cash & Equivalents $313.4M
Short-Term Investments
Other Short-Term Assets $38.22M
YoY Change -3.7%
Inventory $10.71M
Prepaid Expenses
Receivables $177.3M
Other Receivables $0.00
Total Short-Term Assets $539.6M
YoY Change 105.79%
LONG-TERM ASSETS
Property, Plant & Equipment $202.8M
YoY Change -0.68%
Goodwill $591.5M
YoY Change 1.76%
Intangibles $88.14M
YoY Change -9.46%
Long-Term Investments $117.6M
YoY Change 20.74%
Other Assets $56.18M
YoY Change -2.32%
Total Long-Term Assets $1.188B
YoY Change 1.63%
TOTAL ASSETS
Total Short-Term Assets $539.6M
Total Long-Term Assets $1.188B
Total Assets $1.728B
YoY Change 20.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.20M
YoY Change 39.53%
Accrued Expenses $158.3M
YoY Change 0.42%
Deferred Revenue
YoY Change
Short-Term Debt $13.60M
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $282.0M
YoY Change -0.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $12.85M
YoY Change 2.77%
Total Long-Term Liabilities $12.85M
YoY Change -55.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $282.0M
Total Long-Term Liabilities $12.85M
Total Liabilities $544.1M
YoY Change -1.27%
SHAREHOLDERS EQUITY
Retained Earnings $2.506B
YoY Change 11.55%
Common Stock $1.436B
YoY Change 17.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.761B
YoY Change 6.52%
Treasury Stock Shares
Shareholders Equity $1.183B
YoY Change
Total Liabilities & Shareholders Equity $1.728B
YoY Change 20.71%

Cashflow Statement

Concept 2024 Q1
OPERATING ACTIVITIES
Net Income $65.02M
YoY Change 20.13%
Depreciation, Depletion And Amortization $15.81M
YoY Change 6.82%
Cash From Operating Activities $84.55M
YoY Change 39.77%
INVESTING ACTIVITIES
Capital Expenditures $12.16M
YoY Change -28.54%
Acquisitions $7.300M
YoY Change
Other Investing Activities $8.000K
YoY Change -94.24%
Cash From Investing Activities -$19.39M
YoY Change 13.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.77M
YoY Change -73.52%
NET CHANGE
Cash From Operating Activities 84.55M
Cash From Investing Activities -19.39M
Cash From Financing Activities -15.77M
Net Change In Cash 49.39M
YoY Change -407.32%
FREE CASH FLOW
Cash From Operating Activities $84.55M
Capital Expenditures $12.16M
Free Cash Flow $72.39M
YoY Change 66.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000019584
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
1-8351
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
CHEMED CORPORATION
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0791746
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
255 E. Fifth Street
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2600
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Cincinnati
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45202
CY2024Q1 dei City Area Code
CityAreaCode
513
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
762-6690
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Security12b Title
Security12bTitle
Capital Stock $1 Par Value
CY2024Q1 dei Trading Symbol
TradingSymbol
CHE
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15139240
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
313350000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263958000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
177334000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181511000
CY2024Q1 us-gaap Inventory Net
InventoryNet
10712000
CY2023Q4 us-gaap Inventory Net
InventoryNet
12004000
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
9790000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
13166000
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
28431000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
30204000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
539617000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
500843000
CY2024Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
117649000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
106126000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
365074000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
354872000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202784000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203840000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
131751000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126387000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51485000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
48965000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
88137000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
90264000
CY2024Q1 us-gaap Goodwill
Goodwill
591519000
CY2023Q4 us-gaap Goodwill
Goodwill
585017000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56176000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55618000
CY2024Q1 us-gaap Assets
Assets
1727633000
CY2023Q4 us-gaap Assets
Assets
1668095000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
56203000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
64034000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
27353000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6858000
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
62055000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
58568000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49802000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
88381000
CY2024Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
7183000
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
6386000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39279000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38635000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40099000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49188000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
281974000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
312050000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24899000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30321000
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
117550000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
104069000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106861000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100776000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12854000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13003000
CY2024Q1 us-gaap Liabilities
Liabilities
544138000
CY2023Q4 us-gaap Liabilities
Liabilities
560219000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37297015
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37183681
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
37297000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
37184000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1398733000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1341273000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2505892000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2446925000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
22212667
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
22148927
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2760543000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2719588000
CY2024Q1 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2116000
CY2023Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2082000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1183495000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1107876000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1727633000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1668095000
CY2024Q1 us-gaap Revenues
Revenues
589233000
CY2023Q1 us-gaap Revenues
Revenues
560157000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
385127000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
370705000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115873000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100095000
CY2024Q1 us-gaap Depreciation
Depreciation
13287000
CY2023Q1 us-gaap Depreciation
Depreciation
12286000
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2521000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2513000
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-92000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1739000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
516900000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
487338000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
72333000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
72819000
CY2024Q1 us-gaap Interest Expense
InterestExpense
425000
CY2023Q1 us-gaap Interest Expense
InterestExpense
1551000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12577000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-103000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84485000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71165000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19468000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17044000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65017000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.30
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.62
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15121000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14966000
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.24
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15339000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15110000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.38
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65017000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15808000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14799000
CY2024Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
9106000
CY2023Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
2024000
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9025000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
8482000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5422000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3195000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
80000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
95000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5345000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14318000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1302000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
391000
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1909000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1236000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-43012000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-24109000
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
23871000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
19118000
CY2024Q1 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-25000
CY2023Q1 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
632000
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12243000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2173000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
13332000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5313000
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
406000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
122000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84549000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60492000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12163000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17020000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7300000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
86000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
146000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
139000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19385000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17013000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38460000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
37242000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25680000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6050000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5685000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5725000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3166000
CY2024Q1 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-2115000
CY2023Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
76250000
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-664000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-130000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15772000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59551000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
49392000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16072000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263958000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74126000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
313350000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58054000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1107876000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65017000
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.40
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6050000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
49648000
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
32344000
CY2024Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-652000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1183495000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
798715000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.38
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5685000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
33020000
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-118000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
880053000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
3300000
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1700000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
56000
CY2024Q1 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
723000
CY2023Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
690000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">ESTIMATES</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying Notes. Actual results could differ from those estimates. Disclosures of after-tax expenses and adjustments are based on estimates of the effective income tax rates for the applicable segments.</span>
CY2024Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
2200000
CY2023Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
2000000.0
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363416000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
354007000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
319105000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310478000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65017000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
65017000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15121000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.30
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
162000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
65017000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15339000
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.24
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
54121000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14966000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.62
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
94000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
50000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
54121000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15110000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
326000
CY2024Q1 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
8334000
CY2023Q1 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
-321000
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
4243000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
150000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12577000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-103000
CY2024Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
up to 5 years
CY2024Q1 us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
within 1 year
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
131751000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126387000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39279000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38635000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106861000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100776000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
146140000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
139411000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
15582000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14906000
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
23000
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
23000
CY2024Q1 us-gaap Lease Cost
LeaseCost
15559000
CY2023Q1 us-gaap Lease Cost
LeaseCost
14883000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
12453000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
12668000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16559000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6845000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y11M1D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0335
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
34596000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
39126000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30524000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18547000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13678000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
23613000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
160084000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13944000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
146140000
CY2024Q1 che Operating Lease Payments Include To Extended Lease Terms
OperatingLeasePaymentsIncludeToExtendedLeaseTerms
1700000
CY2024Q1 che Lessee Operating Lease Lease Signed But Not Yet Commenced Payments
LesseeOperatingLeaseLeaseSignedButNotYetCommencedPayments
493000
CY2024Q1 che Oas Receivable
OasReceivable
46968000
CY2024Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
13421000
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
5873000
CY2024Q1 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
13600000
CY2023Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
15700000
CY2023Q4 che Oas Receivable
OasReceivable
46968000
CY2024Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
3741000
CY2023Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
3651000
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2205000
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2139000
CY2024Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1191000
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1197000
CY2024Q1 us-gaap Other Receivables
OtherReceivables
2071000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
1663000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56176000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55618000
CY2024Q1 che Retention Bonus
RetentionBonus
8855000
CY2023Q4 che Retention Bonus
RetentionBonus
13245000
CY2024Q1 che Medicare Cap Liability
MedicareCapLiability
6097000
CY2023Q4 che Medicare Cap Liability
MedicareCapLiability
8901000
CY2024Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
3700000
CY2023Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
4641000
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
21447000
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
22401000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40099000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49188000
CY2024Q1 che Percentage Of Individual Amounts Of Total Current Liabilities
PercentageOfIndividualAmountsOfTotalCurrentLiabilities
0.05
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
32344000
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
50000
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
646.87
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000.0
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000.0
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000.0
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
281700000
CY2023Q4 us-gaap Goodwill
Goodwill
585017000
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
6550000
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-48000
CY2024Q1 us-gaap Goodwill
Goodwill
591519000

Files In Submission

Name View Source Status
0001562762-24-000106-index-headers.html Edgar Link pending
0001562762-24-000106-index.html Edgar Link pending
0001562762-24-000106.txt Edgar Link pending
0001562762-24-000106-xbrl.zip Edgar Link pending
che-20240331.xsd Edgar Link pending
che-20240331x10q.htm Edgar Link pending
che-20240331xex31_1.htm Edgar Link pending
che-20240331xex31_2.htm Edgar Link pending
che-20240331xex32_1.htm Edgar Link pending
che-20240331xex32_2.htm Edgar Link pending
che-20240331x10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
che-20240331_def.xml Edgar Link unprocessable
che-20240331_lab.xml Edgar Link unprocessable
che-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
che-20240331_cal.xml Edgar Link unprocessable